Papers in Clinical Cancer Bulletin
Page 1 · newest first
- Clinical advances in proton spatially fractionated radiation therapyClinical Cancer Bulletin · 2026
- DNA damage omics: concepts, genome-wide mapping technologies, and research perspectivesClinical Cancer Bulletin · 2026
- Artificial intelligence for overcoming resistance and safety challenges in cancer stem cell-targeted cellular immunotherapyClinical Cancer Bulletin · 2026
- Stereotactic body radiotherapy and the tumor microenvironment in pancreatic ductal adenocarcinoma: from mechanistic remodeling to immunotherapy combinationsClinical Cancer Bulletin · 2026
- T cell receptor-engineered T cells for hepatocellular carcinoma: next steps and future perspectivesClinical Cancer Bulletin · 2026
- HPV vaccination and cervical cancer deaths: from incidence reduction to mortality preventionClinical Cancer Bulletin · 2026
- Pola-R-CHP in previously untreated DLBCL with international prognostic index score 0–1: a multicenter real-world retrospective study in ChinaClinical Cancer Bulletin · 2026
- The dawn of RAS-targeted therapy: a landmark breakthrough of daraxonrasib in pancreatic cancerClinical Cancer Bulletin · 2026
- Exploring mitochondrial central dogma in cancer from a metabolic perspectiveClinical Cancer Bulletin · 2026
- Patient-derived tumor organoid co-culture systems as translational platforms for cancer immunotherapy and precision oncologyClinical Cancer Bulletin · 2026
- Radiotherapy-induced immunity is real but incomplete: nano-immunoadjuvants as immune amplifiers in radioimmunotherapyClinical Cancer Bulletin · 2026
- A heterogeneous multimodal ensemble framework for multi-omics breast cancer prognosisClinical Cancer Bulletin · 2026
- The CCL2/CCR2 axis in irradiated tumors: orchestrating immune recruitment and microenvironment remodelingClinical Cancer Bulletin · 2026
- Comparative efficacy and safety of postoperative adjuvant therapies after curative resection for hepatocellular carcinoma: a network meta-analysisClinical Cancer Bulletin · 2026
- Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-associated myocarditis (2026 edition)Clinical Cancer Bulletin · 2026
- Targeting HER-2 pathway in presence of cardiac dysfunction: the walk on a tight ropeClinical Cancer Bulletin · 2026
- Computational stratification and engineering framework of the PDCD1/CD2 immune axis in triple-negative breast cancerClinical Cancer Bulletin · 2026
- Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastasis (2025 Edition)Clinical Cancer Bulletin · 2026
- Lineage infidelity in small-cell lung cancer: driving subtype transitions and acquired therapeutic vulnerabilitiesClinical Cancer Bulletin · 2026
- Global research status and trends in the AI-driven anticancer drug design: a bibliometric analysis of 2011–2025Clinical Cancer Bulletin · 2026
- Dual role of interleukin-2 in tumor-infiltrating lymphocyte therapyClinical Cancer Bulletin · 2026
- Causal relationships between cerebral cortical architecture and blood cancers: the disease spectrum is different because the brains look differentClinical Cancer Bulletin · 2026
- Conditional reprogramming in eyelid tumors: bridging the model gap in meibomian gland carcinomaClinical Cancer Bulletin · 2026
- Chinese expert consensus on ultrasound-guided percutaneous lung needle biopsy (2025 Edition)Clinical Cancer Bulletin · 2026
- Chinese expert consensus on robotic surgery for colorectal cancer (2025 edition)Clinical Cancer Bulletin · 2026
- Chinese expert consensus on the management of adverse events to HER2-targeted antibody–drug conjugates in digestive system cancers (2025 edition)Clinical Cancer Bulletin · 2026
- Emerging biomarkers for early detection of lung cancerClinical Cancer Bulletin · 2025
- Emerging biomarkers for early detection of lung cancerClinical Cancer Bulletin · 2025
- Advancing cancer care through artificial intelligence: from innovative models to clinical decision-making and regulatory integrationClinical Cancer Bulletin · 2025
- Advances in CAR-T cell therapy for refractory diseases: challenges, innovations, clinical breakthroughs, and future prospectsClinical Cancer Bulletin · 2025
- Multi-omics and Mendelian randomization reveal ABC transporter alternative splicing as a pan-cancer prognostic marker and therapeutic targetClinical Cancer Bulletin · 2025
- Friend or foe? Multi-omics analysis unravels the complex identity of key pyroptosis factor CASP9 in clear cell renal cell carcinomaClinical Cancer Bulletin · 2025
- Application and Advances of Adoptive Cell Therapy for MelanomaClinical Cancer Bulletin · 2025
- Multi-disciplinary expert consensus on cutaneous adverse events caused by immune checkpoint inhibitors (2025)Clinical Cancer Bulletin · 2025
- Management of Cytokine Release Syndrome (CRS) following CAR T-cell therapy: a comprehensive reviewClinical Cancer Bulletin · 2025
- Prognostic and therapeutic implications of lipid metabolism-related lncRNAs in lung adenocarcinoma: a comprehensive analysis integrating transcriptomics, Mendelian randomization, and immunotherapy sensitivityClinical Cancer Bulletin · 2025
- Small molecules in lung cancer targeted therapy: a two-decade bibliometric analysis and visualization (2005–2024)Clinical Cancer Bulletin · 2025
- Immunotherapy for hepatocellular carcinomaClinical Cancer Bulletin · 2025
- Immune checkpoint inhibitor-associated myocardial infarction in a patient with lung cancer undergoing six cycles of immunotherapy: a case reportClinical Cancer Bulletin · 2025
- Therapeutic vaccine strategies in cancer: advances, challenges, and future directionsClinical Cancer Bulletin · 2025
- Guideline of precisional testing in intrahepatic cholangiocarcinoma: an international expert consensusClinical Cancer Bulletin · 2025
- Management of multisystemic irAEs associated with atezolizumab/tiragolumab combination therapy in a patient with lung adenocarcinoma: case report and reviewClinical Cancer Bulletin · 2025
- Pembrolizumab-induced pemphigoid nodularis manifesting as an erythema multiforme-like eruption: a case reportClinical Cancer Bulletin · 2025
- Comprehensive evaluation of clinical prognostic parameters in a real-world cohort of 812 patients with multiple myelomaClinical Cancer Bulletin · 2025
- Rethinking contralateral breast cancer: latest insights on risk, prevention, and outcomesClinical Cancer Bulletin · 2025
- Identification of a lysosome-related prognostic signature to predict prognosis, tumor microenvironment and therapeutic responses in lung adenocarcinomaClinical Cancer Bulletin · 2025
- Proteomics efforts for hepatocellular carcinoma drug developmentClinical Cancer Bulletin · 2024
- Insights for the immunotherapy in malignant melanoma: a new revolutionClinical Cancer Bulletin · 2024
- Primary cutaneous scrotal angiosarcoma: a case report and literature reviewClinical Cancer Bulletin · 2024
- MyD88's function in the emergence and growth of tumorsClinical Cancer Bulletin · 2024